Market Cap 138.61B
Revenue (ttm) 62.58B
Net Income (ttm) 7.77B
EPS (ttm) N/A
PE Ratio 7.80
Forward PE 8.15
Profit Margin 12.42%
Debt to Equity Ratio 0.71
Volume 58,576,000
Avg Vol 41,853,625
Day's Range N/A - N/A
Shares Out 5.70B
Stochastic %K 42%
Beta 0.35
Analysts Sell
Price Target $29.20

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
zMIMI
zMIMI Jul. 6 at 11:32 PM
$PFE is killing my portfolio. Hopefully $VCRE has the antidote. 😁
0 · Reply
MrPeanutEsquire
MrPeanutEsquire Jul. 6 at 10:58 PM
$PFE The cheapest pharma stock by every metric there is. Dont see how it would be possible to go any lower but I thought that at 24.50...
1 · Reply
ItsCarRamRod
ItsCarRamRod Jul. 6 at 9:33 PM
$PFE When Bourla was appointed CEO in Jan 1st 2019 PFE stock was $40 a share and today it cannot even hold $24. So bourla the wealth destroyed has shredded -40% of the company value and nothing to show for it but a sky high salary and 100's of millions in bonus money in his pocket.
1 · Reply
SmartAlphaa
SmartAlphaa Jul. 6 at 9:24 PM
Interesting that $NVO is keeping a decent stake in $CRNX while letting $VRTX take the lead. Feels like Novo may not be as focused on rare disease as the market once thought, or at least not enough to stretch capacity there. $VRTX at roughly the same mkt cap as $PFE is notable too. No near-term LOE, but the story still looks heavily CF-driven, with only a little pain exposure.
0 · Reply
DivvyInvestor
DivvyInvestor Jul. 6 at 8:54 PM
$PFE 'MARCHING' A Little Higher AH
1 · Reply
ItsCarRamRod
ItsCarRamRod Jul. 6 at 8:47 PM
$PFE typical day for PFE, market goes up a solid 1% while PFE drops to 52 week lows. Bourla the wealth destroyer strikes again.
1 · Reply
Redgreenredgreen
Redgreenredgreen Jul. 6 at 8:15 PM
$PFE give us a share buyback
1 · Reply
DenchDaddy
DenchDaddy Jul. 6 at 7:59 PM
$PFE this is my big dividend payer - but we can agree it’s doing shocking atm
0 · Reply
DivvyInvestor
DivvyInvestor Jul. 6 at 7:51 PM
$PFE SMALL RALLY IT APPEARS....... INTO THE CLOSE !
0 · Reply
MrPeanutEsquire
MrPeanutEsquire Jul. 6 at 7:48 PM
$PFE Weve gotten destroyed by boats (as an investment class) literally every single week for the last 14 weeks. wtf
2 · Reply
Latest News on PFE
Options Corner: PFE Downgrade, Stock Slides Near 52-Week Low

Jul 6, 2026, 10:00 AM EDT - 11 hours ago

Options Corner: PFE Downgrade, Stock Slides Near 52-Week Low


Pfizer downgraded to Hold from Buy at HSBC

2026-07-06T09:50:29.000Z - 15 hours ago

Pfizer downgraded to Hold from Buy at HSBC


Pfizer Declares Third-Quarter 2026 Dividend

Jun 24, 2026, 3:52 PM EDT - 12 days ago

Pfizer Declares Third-Quarter 2026 Dividend


Pfizer dismissed from US states' drug price-fixing lawsuit

Jun 24, 2026, 10:51 AM EDT - 12 days ago

Pfizer dismissed from US states' drug price-fixing lawsuit


Pfizer (PFE) Shares Sink After Surprise CFO Exit

2026-06-18T18:35:11.000Z - 18 days ago

Pfizer (PFE) Shares Sink After Surprise CFO Exit


Pfizer reaffirms all components of FY26 guidance

2026-06-18T17:30:31.000Z - 18 days ago

Pfizer reaffirms all components of FY26 guidance


Pfizer CFO Dave Denton to step down, leave company in August

Jun 18, 2026, 6:52 AM EDT - 18 days ago

Pfizer CFO Dave Denton to step down, leave company in August


Pfizer Announces Chief Financial Officer Transition

Jun 18, 2026, 6:45 AM EDT - 18 days ago

Pfizer Announces Chief Financial Officer Transition


US FDA approves Pfizer's bleeding disorder drug for children

Jun 8, 2026, 6:49 AM EDT - 4 weeks ago

US FDA approves Pfizer's bleeding disorder drug for children


Pfizer Transcript: Study update

Jun 6, 2026, 11:00 AM EDT - 4 weeks ago

Pfizer Transcript: Study update


Pfizer Slides: Study update

Jun 6, 2026, 11:00 AM EDT - 4 weeks ago

Pfizer Slides: Study update


Pfizer Press release: Study update

Jun 6, 2026, 11:00 AM EDT - 4 weeks ago

Pfizer Press release: Study update


Mailbag: A Follow-Up on Pfizer & Other Questions

May 30, 2026, 9:22 AM EDT - 5 weeks ago

Mailbag: A Follow-Up on Pfizer & Other Questions

AGNC LAND NLY PFFA


Pfizer CEO on Drug Pipeline, Trump's Pick to Lead CDC

May 5, 2026, 4:09 PM EDT - 2 months ago

Pfizer CEO on Drug Pipeline, Trump's Pick to Lead CDC


Pfizer CEO on AI-designed molecule, and race to use new tech

May 5, 2026, 4:02 PM EDT - 2 months ago

Pfizer CEO on AI-designed molecule, and race to use new tech


3 Dividend Stocks for May 2026

May 5, 2026, 11:30 AM EDT - 2 months ago

3 Dividend Stocks for May 2026

SYY WSO


Pfizer Earnings Call Transcript: Q1 2026

May 5, 2026, 10:00 AM EDT - 2 months ago

Pfizer Earnings Call Transcript: Q1 2026


Pfizer Earnings release: Q1 2026

May 5, 2026, 10:00 AM EDT - 2 months ago

Pfizer Earnings release: Q1 2026


Pfizer Quarterly report: Q1 2026

May 5, 2026, 10:00 AM EDT - 2 months ago

Pfizer Quarterly report: Q1 2026


Pfizer Slides: Q1 2026

May 5, 2026, 10:00 AM EDT - 2 months ago

Pfizer Slides: Q1 2026


Pfizer Posts Better-Than-Expected Revenue, Profit

May 5, 2026, 8:35 AM EDT - 2 months ago

Pfizer Posts Better-Than-Expected Revenue, Profit


Pfizer Revenue Rises But Profit Falls Amid Boosted R&D Spending

May 5, 2026, 7:23 AM EDT - 2 months ago

Pfizer Revenue Rises But Profit Falls Amid Boosted R&D Spending


Why selling these 3 dividend stocks could be a mistake

May 5, 2026, 7:05 AM EDT - 2 months ago

Why selling these 3 dividend stocks could be a mistake

EPD UPS


zMIMI
zMIMI Jul. 6 at 11:32 PM
$PFE is killing my portfolio. Hopefully $VCRE has the antidote. 😁
0 · Reply
MrPeanutEsquire
MrPeanutEsquire Jul. 6 at 10:58 PM
$PFE The cheapest pharma stock by every metric there is. Dont see how it would be possible to go any lower but I thought that at 24.50...
1 · Reply
ItsCarRamRod
ItsCarRamRod Jul. 6 at 9:33 PM
$PFE When Bourla was appointed CEO in Jan 1st 2019 PFE stock was $40 a share and today it cannot even hold $24. So bourla the wealth destroyed has shredded -40% of the company value and nothing to show for it but a sky high salary and 100's of millions in bonus money in his pocket.
1 · Reply
SmartAlphaa
SmartAlphaa Jul. 6 at 9:24 PM
Interesting that $NVO is keeping a decent stake in $CRNX while letting $VRTX take the lead. Feels like Novo may not be as focused on rare disease as the market once thought, or at least not enough to stretch capacity there. $VRTX at roughly the same mkt cap as $PFE is notable too. No near-term LOE, but the story still looks heavily CF-driven, with only a little pain exposure.
0 · Reply
DivvyInvestor
DivvyInvestor Jul. 6 at 8:54 PM
$PFE 'MARCHING' A Little Higher AH
1 · Reply
ItsCarRamRod
ItsCarRamRod Jul. 6 at 8:47 PM
$PFE typical day for PFE, market goes up a solid 1% while PFE drops to 52 week lows. Bourla the wealth destroyer strikes again.
1 · Reply
Redgreenredgreen
Redgreenredgreen Jul. 6 at 8:15 PM
$PFE give us a share buyback
1 · Reply
DenchDaddy
DenchDaddy Jul. 6 at 7:59 PM
$PFE this is my big dividend payer - but we can agree it’s doing shocking atm
0 · Reply
DivvyInvestor
DivvyInvestor Jul. 6 at 7:51 PM
$PFE SMALL RALLY IT APPEARS....... INTO THE CLOSE !
0 · Reply
MrPeanutEsquire
MrPeanutEsquire Jul. 6 at 7:48 PM
$PFE Weve gotten destroyed by boats (as an investment class) literally every single week for the last 14 weeks. wtf
2 · Reply
DivvyInvestor
DivvyInvestor Jul. 6 at 7:44 PM
$PFE POS
0 · Reply
DivvyInvestor
DivvyInvestor Jul. 6 at 7:37 PM
$PFE FIRE BOURLA NOW
0 · Reply
AFJuvat
AFJuvat Jul. 6 at 7:31 PM
$PFE The name is BOURLA
0 · Reply
DivvyInvestor
DivvyInvestor Jul. 6 at 7:18 PM
$PFE POWER HOUR..... POWER UP PFE !
2 · Reply
AngusMacbeth
AngusMacbeth Jul. 6 at 7:14 PM
$PFE Added. I think it continues paying its divvy and it will do small to medium sized acquisitions.
0 · Reply
DivvyInvestor
DivvyInvestor Jul. 6 at 7:10 PM
$PFE WHEN BOURLA GETS FIRED !
1 · Reply
Chickenstick1
Chickenstick1 Jul. 6 at 6:59 PM
$PFE If this doesn't cut it's dividend when it reports, You can expect this to pop + $27.
1 · Reply
Bleu_
Bleu_ Jul. 6 at 6:43 PM
$PFE Added shares! too Cheap to igonre!
0 · Reply
BarkingPuppy
BarkingPuppy Jul. 6 at 6:30 PM
0 · Reply
Crom5775
Crom5775 Jul. 6 at 6:26 PM
$PFE back in the buy zone as its tags the bottom of its box.
1 · Reply
ultraviolin
ultraviolin Jul. 6 at 6:19 PM
$CRSP Exited at 62.5, entered $PFE §30k
2 · Reply
TraderDaKing
TraderDaKing Jul. 6 at 6:16 PM
$ELTP $JNJ $PFE $GME Big Pharma moving in to grab the best kept secret out of New Jersey. Quarterly swing from loss to profit through FY 2026 Across FY 2026, Elite Pharmaceuticals moved from a basic EPS loss of US$0.0055 in Q1, when net income excluding extra items was a loss of US$5.9 million on US$40.2 million of revenue, to positive basic EPS in the remaining quarters, ending Q4 with basic EPS of US$0.0171 and net income excluding extra items of US$18.5 million on US$40.7 million of revenue.
0 · Reply